Treated in only 3 VISITS!   214.379.2700
  • Stereotactic Body Radiation Shows High Cure Rate

    Men who are diagnosed with prostate cancer that demands intervention to increase survival changes may find a relatively new form of radiation offers the hope they’re after. Stereotactic Body Radiation Therapy, or SBRT for short, has been shown to have a 98 percent cure rate in patients who are treated with this option. SBRT involves the use of specialized external...

  • Can Eating Right Lower Prostate Cancer Risks?

    With more than 180,000 American men likely to face down a diagnosis of prostate cancer in the coming year, many of those at risk seek out ways to drop their personal exposure to this disease. While many of the risk factors for prostate cancer are not changeable, studies are showing there are some steps men can take to lower...

  • Hormone Therapy and Prostate Cancer: Understanding its Use

    Men who are diagnosed with prostate cancer may find their healthcare providers recommending a treatment known as androgen deprivation therapy. This hormonal treatment is meant to reduce the levels of male hormones in the body. These hormones, also called androgens, are specifically targeted to prevent them from affecting prostate cancer cells. Androgens are known to stimulate the growth of prostate...

  • How is Prostate Cancer Diagnosed?

    Prostate cancer is among the most commonly diagnosed forms of cancer among American males. An estimated 180,000 American men, in fact, will be diagnosed with it in the coming year. A concern for all males as they age, this particular form of cancer can often be successfully treated if it is caught in its earliest stages. Prostate cancer can be...

  • Gene Defect May Offer Insights for Targeted Prostate Cancer Treatments

    A particular gene found in many prostate cancer tumors may provide valuable insights in regard to treatment options. The gene, called CHD1, is mutated in up to 27 percent of all prostate cancer tumors. The loss of CHD1 has been shown to sensitize prostate cancer cells to particular drugs, including PARP inhibitors, a recent study found. The findings may...

  • New Method Helps Identify High-Risk Prostate Cancer

    Many of the nearly 200,000 American men who will be diagnosed with prostate cancer this year will find their cancer is considered low-risk. Often slow growing, this type of prostate cancer is typically considered so non-aggressive that some men may find their doctors suggesting a treatment method known as active surveillance. This involves careful monitoring of the tumor, but...

  • Can Radiation Make a Difference in Locally Advanced Prostate Cancer?

    Men who are diagnosed with more advanced cases of prostate cancer may find their treatment options limited. One choice, however, can produce positive results while improving outcomes. Radiation therapy can and does play a very big role in the treatment of more advanced cases of this disease. When used in conjunction with other therapies, such as androgen-deprivation therapy, the...

  • Imaging Test May Offer Way to Detect Prostate Cancer Early

    Routine early screening for prostate cancer has been largely credited with a sharp decline in the number of deaths attributed to this disease each year. In fact, while an estimated 180,000 American men are diagnosed annually, only about 26,000 die from the disease. A relatively recent development in prostate cancer screening, however, has given rise to fears that these...

  • Genetic, Molecular Testing Shows Promise in Prostate Cancer

    While a replacement for the prostate-specific antigen test for early screening of prostate cancer has not yet been identified, prognostic tests currently available and those under development offer hope for more targeted treatments when the disease is diagnosed. Clinicians say molecular and gene tests can offer insights that better guide the treatment decision-making process. Molecular assays are already making headway...

  • Sexual Activity May Cause PSA Fluctuations After Cancer Treatment

    Men who are treated for prostate cancer using curative radiation therapy techniques, such as brachytherapy, may get a surprise they’re not expecting during routine follow-up prostate-specific antigen tests. A bounce in the numbers that occurs in some cases is no major cause for alarm though, researchers say. This up-and-down fluctuation in numbers is believed to be caused by nothing...